Name | Number of supported studies | Average coverage | |
---|---|---|---|
placental villous trophoblast | 3 studies | 35% ± 19% |
Insufficient scRNA-seq data for expression of FOXO4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2404.31 | 244 / 245 | 100% | 29.50 | 502 / 502 |
brain | 100% | 4556.88 | 2642 / 2642 | 100% | 36.38 | 702 / 705 |
thymus | 100% | 1844.24 | 650 / 653 | 100% | 26.90 | 603 / 605 |
adrenal gland | 100% | 5161.08 | 258 / 258 | 99% | 32.13 | 228 / 230 |
breast | 100% | 2287.83 | 459 / 459 | 99% | 23.78 | 1108 / 1118 |
bladder | 100% | 2565.90 | 21 / 21 | 99% | 20.98 | 498 / 504 |
ovary | 100% | 3452.03 | 180 / 180 | 99% | 18.66 | 424 / 430 |
intestine | 100% | 2792.23 | 966 / 966 | 98% | 20.36 | 519 / 527 |
uterus | 100% | 2604.64 | 170 / 170 | 98% | 19.82 | 452 / 459 |
stomach | 99% | 1722.39 | 357 / 359 | 98% | 19.29 | 281 / 286 |
kidney | 98% | 1299.46 | 87 / 89 | 99% | 17.31 | 890 / 901 |
lung | 99% | 1602.90 | 571 / 578 | 97% | 14.84 | 1122 / 1155 |
esophagus | 100% | 2587.48 | 1443 / 1445 | 93% | 11.46 | 171 / 183 |
pancreas | 93% | 1022.69 | 306 / 328 | 100% | 20.63 | 178 / 178 |
skin | 92% | 1709.05 | 1666 / 1809 | 99% | 28.34 | 469 / 472 |
liver | 59% | 432.45 | 133 / 226 | 95% | 12.21 | 384 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 47.28 | 80 / 80 |
muscle | 100% | 5341.55 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2182.63 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.25 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.13 | 1 / 1 |
adipose | 100% | 2170.97 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1757.16 | 1321 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 3131.72 | 902 / 929 | 0% | 0 | 0 / 0 |
heart | 95% | 1599.88 | 814 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 9.79 | 24 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0070317 | Biological process | negative regulation of G0 to G1 transition |
GO_0051151 | Biological process | negative regulation of smooth muscle cell differentiation |
GO_0014911 | Biological process | positive regulation of smooth muscle cell migration |
GO_1990785 | Biological process | response to water-immersion restraint stress |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_0007095 | Biological process | mitotic G2 DNA damage checkpoint signaling |
GO_0031667 | Biological process | response to nutrient levels |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0007517 | Biological process | muscle organ development |
GO_0048863 | Biological process | stem cell differentiation |
GO_0006979 | Biological process | response to oxidative stress |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0003676 | Molecular function | nucleic acid binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0008013 | Molecular function | beta-catenin binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FOXO4 |
Protein name | Forkhead box protein O4 (Fork head domain transcription factor AFX1) |
Synonyms | AFX MLLT7 AFX1 |
Description | FUNCTION: Transcription factor involved in the regulation of the insulin signaling pathway. Binds to insulin-response elements (IREs) and can activate transcription of IGFBP1. Down-regulates expression of HIF1A and suppresses hypoxia-induced transcriptional activation of HIF1A-modulated genes. Also involved in negative regulation of the cell cycle. Involved in increased proteasome activity in embryonic stem cells (ESCs) by activating expression of PSMD11 in ESCs, leading to enhanced assembly of the 26S proteasome, followed by higher proteasome activity. . |
Accessions | P98177 ENST00000374259.8 [P98177-1] ENST00000341558.3 [P98177-2] |